INS and diabetes mellitus: We speculate that these results reflecting the reversal of diabetes in Activin-a treatment mice could be attributed to two possibilities: (1) GFP+BMSC contributes to a new ß-cell generation that resulted in increased insulin and reduced blood glucose, and (2) Activin-a treatment substantially stimulate insulin biosynthesis or release from pre-existing ß-cells.